Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-19-036524
Filing Date
2019-06-12
Accepted
2019-06-12 18:37:56
Documents
2
Period of Report
2017-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 1936
2 POA DOCUMENT poa.txt EX-24.3A_859540 2492
  Complete submission text file 0001209191-19-036524.txt   5819
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Issuer) CIK: 0001175505 (see all company filings)

EIN.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TESARO, INC. 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address
Nicholson Garry A (Reporting) CIK: 0001640861 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36070 | Film No.: 19894537